Abbott smartphone-compatible cardiac monitor gains FDA clearance

Daniel Allar | | Cardiovascular Business | Heart Rhythm

Abbott has received FDA clearance for its smartphone-compatible insertable cardiac monitor (ICM), the healthcare company announced Oct. 23. The device allows a patient to actively monitor his heart activity while giving physicians the ability to identify arrhythmias remotely.

The Confirm Rx ICM, which is implanted just underneath the skin in the chest during a minimally invasive outpatient procedure, is paired with Abbott’s myMerlin mobile application. In the app, patients can record episodes of irregular heartbeat and send that information to their doctors, who have continuous access to data from the ICM.

"Confirm Rx shows what we can do with cutting edge communication technology and the most advanced medical devices that provide new opportunities to improve patient care," Avi Fischer, MD, divisional vice president and medical director of Abbott's Cardiac Rhythm Management business, said in a press release. "By offering a device that uses Bluetooth wireless technology from the patient's smartphone, we can help physicians easily and remotely diagnose potentially dangerous abnormal heart beats without requiring the patient to use a separate or cumbersome recording device."

Abbott received CE mark approval for the device in May.

""
Daniel Allar

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Related Content

LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."